Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary surfactant and its clinical application]

T Fujiwara1

  • 1Department of Pediatrics, Iwate Medical University.

Nihon Kyobu Shikkan Gakkai Zasshi
|December 1, 1994
PubMed
Summary

Prophylactic surfactant replacement therapy (SRT) with Surfactant-TA completely prevents respiratory distress syndrome (RDS) in preterm neonates. This approach significantly reduces chronic lung disease incidence, outperforming rescue strategies and other surfactants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91.

Acta paediatrica Japonica : Overseas edition·1992
Same author

An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum.

Biochemistry·1992
Same author

Anti-Golgi antibody in rheumatoid arthritis patients recognizes a novel antigen of 79 kDa (doublet) by western blot.

Scandinavian journal of immunology·1992
Same author

Seed-specific repression of GUS activity in tobacco plants by antisense RNA.

Plant molecular biology·1992
Same author

[Clinical study of total parathyroidectomy and autotransplantation for secondary hyperparathyroidism].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·1992
Same author

Purification, characterization, cloning, and expression of a glutamic acid-specific protease from Bacillus licheniformis ATCC 14580.

The Journal of biological chemistry·1992

Area of Science:

  • Neonatology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Respiratory distress syndrome (RDS) is a significant concern in preterm neonates.
  • Surfactant replacement therapy (SRT) is a key treatment for RDS.
  • Understanding surfactant biophysical properties and clinical efficacy is crucial.

Purpose of the Study:

  • To evaluate the efficacy of Surfactant-TA, a bovine lung surfactant, in preterm neonates with RDS.
  • To compare prophylactic versus rescue SRT strategies.
  • To assess Surfactant-TA's superiority over other available surfactants.

Main Methods:

  • Prospective randomized trial including only neonates with documented surfactant deficiency.
  • Inclusion of clinical experience with Surfactant-TA since 1980.
  • In vivo studies comparing Surfactant-TA with Survanta and synthetic surfactants.

Main Results:

  • Prophylactic Surfactant-TA completely prevented RDS development.
  • A significant reduction in chronic lung disease incidence was observed (OR 0.08, p=0.016).
  • In vivo studies indicated Surfactant-TA's superiority over Survanta and synthetic surfactants.

Conclusions:

  • Prophylactic SRT with Surfactant-TA is highly effective in preventing RDS and reducing chronic lung disease in preterm neonates.
  • Surfactant-TA demonstrates superior efficacy compared to other available surfactant preparations.
  • Targeting surfactant deficiency is key for optimal therapeutic response.

Related Experiment Videos